comparemela.com

Latest Breaking News On - Institutional investors weigh in on galmed pharmaceuticals - Page 1 : comparemela.com

StockNews com Begins Coverage on Galmed Pharmaceuticals (NASDAQ:GLMD)

StockNews.com initiated coverage on shares of Galmed Pharmaceuticals (NASDAQ:GLMD – Free Report) in a report published on Tuesday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Galmed Pharmaceuticals Stock Performance GLMD stock opened at $0.46 on Tuesday. The firm has a market cap of $764,400.00, a price-to-earnings ratio of -0.12 and […]

Galmed Pharmaceuticals (NASDAQ:GLMD) Now Covered by StockNews com

StockNews.com initiated coverage on shares of Galmed Pharmaceuticals (NASDAQ:GLMD – Free Report) in a research note released on Sunday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Galmed Pharmaceuticals Stock Performance Shares of GLMD opened at $0.35 on Friday. The stock has a market cap of $586,488.00, a PE ratio of -0.09 […]

StockNews com Begins Coverage on Galmed Pharmaceuticals (NASDAQ:GLMD)

StockNews.com assumed coverage on shares of Galmed Pharmaceuticals (NASDAQ:GLMD – Free Report) in a research note released on Saturday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Galmed Pharmaceuticals Stock Performance Shares of NASDAQ GLMD opened at $0.39 on Friday. The firm has a market cap of $648,480.00, a PE ratio of […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.